Clinical Trial Update: Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy

View source ↗

Summary

This clinical trial update discusses treatment approaches and outcomes for patients with diffuse large B-cell lymphoma who progressed after a polatuzumab vedoti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Polivy (polatuzumab vedotin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Diffuse Large B Cell Lymphoma (DLBCL) | Status: NOT_YET_RECRUITING